Mitosense

Mitosense is developing targeted therapies for neurodegenerative diseases by utilizing advanced gene editing techniques to modify cellular pathways associated with neurodegeneration. The company aims to improve patient outcomes by addressing the underlying biological mechanisms that lead to cognitive decline and motor function loss.

Traction 9/10

Great Falls, United States · HQ

Founded 201911K+ followers

Biotechnology

Updated 23 months ago

Funding

Raised to date

$4.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

Mitosense is developing targeted therapies for neurodegenerative diseases by utilizing advanced gene editing techniques to modify cellular pathways associated with neurodegeneration. The company aims to improve patient outcomes by addressing the underlying biological mechanisms that lead to cognitive decline and motor function loss.